1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Cancer Antigen Revenue 1.4 Market Analysis by Type 1.4.1 Global Cancer Antigen Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Cancer Antigen 125 1.4.3 Cancer Antigen 15-3 1.4.4 Cancer Antigen 27-29 1.4.5 Cancer Antigen 19-9 1.4.6 Others 1.5 Market by Application 1.5.1 Global Cancer Antigen Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Diagnostic Centres 1.5.4 Ambulatory Surgical Centres 1.5.5 Others 1.6 Coronavirus Disease 2019 (Covid-19): Cancer Antigen Industry Impact 1.6.1 How the Covid-19 is Affecting the Cancer Antigen Industry 1.6.1.1 Cancer Antigen Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Cancer Antigen Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Cancer Antigen Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Cancer Antigen Market Perspective (2015-2026) 2.2 Cancer Antigen Growth Trends by Regions 2.2.1 Cancer Antigen Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Cancer Antigen Historic Market Share by Regions (2015-2020) 2.2.3 Cancer Antigen Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Cancer Antigen Market Growth Strategy 2.3.6 Primary Interviews with Key Cancer Antigen Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Cancer Antigen Players by Market Size 3.1.1 Global Top Cancer Antigen Players by Revenue (2015-2020) 3.1.2 Global Cancer Antigen Revenue Market Share by Players (2015-2020) 3.1.3 Global Cancer Antigen Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Cancer Antigen Market Concentration Ratio 3.2.1 Global Cancer Antigen Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Cancer Antigen Revenue in 2019 3.3 Cancer Antigen Key Players Head office and Area Served 3.4 Key Players Cancer Antigen Product Solution and Service 3.5 Date of Enter into Cancer Antigen Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Cancer Antigen Historic Market Size by Type (2015-2020) 4.2 Global Cancer Antigen Forecasted Market Size by Type (2021-2026) 5 Cancer Antigen Breakdown Data by Application (2015-2026) 5.1 Global Cancer Antigen Market Size by Application (2015-2020) 5.2 Global Cancer Antigen Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Cancer Antigen Market Size (2015-2020) 6.2 Cancer Antigen Key Players in North America (2019-2020) 6.3 North America Cancer Antigen Market Size by Type (2015-2020) 6.4 North America Cancer Antigen Market Size by Application (2015-2020) 7 Europe 7.1 Europe Cancer Antigen Market Size (2015-2020) 7.2 Cancer Antigen Key Players in Europe (2019-2020) 7.3 Europe Cancer Antigen Market Size by Type (2015-2020) 7.4 Europe Cancer Antigen Market Size by Application (2015-2020) 8 Asia-Pacific 8.1 Asia-Pacific Cancer Antigen Market Size (2015-2020) 8.2 Cancer Antigen Key Players in Asia-Pacific (2019-2020) 8.3 Asia-Pacific Cancer Antigen Market Size by Type (2015-2020) 8.4 Asia-Pacific Cancer Antigen Market Size by Application (2015-2020) (2015-2020) (2015-2020) 9 Key Players Profiles 9.1 Thermo Fisher Scientific 9.1.1 Thermo Fisher Scientific Company Details 9.1.2 Thermo Fisher Scientific Business Overview and Its Total Revenue 9.1.3 Thermo Fisher Scientific Cancer Antigen Introduction 9.1.4 Thermo Fisher Scientific Revenue in Cancer Antigen Business (2015-2020)) 9.1.5 Thermo Fisher Scientific Recent Development 9.2 Roche 9.2.1 Roche Company Details 9.2.2 Roche Business Overview and Its Total Revenue 9.2.3 Roche Cancer Antigen Introduction 9.2.4 Roche Revenue in Cancer Antigen Business (2015-2020) 9.2.5 Roche Recent Development 9.3 Tellgen 9.3.1 Tellgen Company Details 9.3.2 Tellgen Business Overview and Its Total Revenue 9.3.3 Tellgen Cancer Antigen Introduction 9.3.4 Tellgen Revenue in Cancer Antigen Business (2015-2020) 9.3.5 Tellgen Recent Development 9.4 Labor Diagnostika Nord 9.4.1 Labor Diagnostika Nord Company Details 9.4.2 Labor Diagnostika Nord Business Overview and Its Total Revenue 9.4.3 Labor Diagnostika Nord Cancer Antigen Introduction 9.4.4 Labor Diagnostika Nord Revenue in Cancer Antigen Business (2015-2020) 9.4.5 Labor Diagnostika Nord Recent Development 9.5 Henso Medical (Hangzhou) 9.5.1 Henso Medical (Hangzhou) Company Details 9.5.2 Henso Medical (Hangzhou) Business Overview and Its Total Revenue 9.5.3 Henso Medical (Hangzhou) Cancer Antigen Introduction 9.5.4 Henso Medical (Hangzhou) Revenue in Cancer Antigen Business (2015-2020) 9.5.5 Henso Medical (Hangzhou) Recent Development 9.6 Multisciences (Lianke) Biotech 9.6.1 Multisciences (Lianke) Biotech Company Details 9.6.2 Multisciences (Lianke) Biotech Business Overview and Its Total Revenue 9.6.3 Multisciences (Lianke) Biotech Cancer Antigen Introduction 9.6.4 Multisciences (Lianke) Biotech Revenue in Cancer Antigen Business (2015-2020) 9.6.5 Multisciences (Lianke) Biotech Recent Development 9.7 Hangzhou AllTest Biotech 9.7.1 Hangzhou AllTest Biotech Company Details 9.7.2 Hangzhou AllTest Biotech Business Overview and Its Total Revenue 9.7.3 Hangzhou AllTest Biotech Cancer Antigen Introduction 9.7.4 Hangzhou AllTest Biotech Revenue in Cancer Antigen Business (2015-2020) 9.7.5 Hangzhou AllTest Biotech Recent Development 9.8 SHINJIN Medics 9.8.1 SHINJIN Medics Company Details 9.8.2 SHINJIN Medics Business Overview and Its Total Revenue 9.8.3 SHINJIN Medics Cancer Antigen Introduction 9.8.4 SHINJIN Medics Revenue in Cancer Antigen Business (2015-2020) 9.8.5 SHINJIN Medics Recent Development 9.9 Xiamen Baysen Medica Tech 9.9.1 Xiamen Baysen Medica Tech Company Details 9.9.2 Xiamen Baysen Medica Tech Business Overview and Its Total Revenue 9.9.3 Xiamen Baysen Medica Tech Cancer Antigen Introduction 9.9.4 Xiamen Baysen Medica Tech Revenue in Cancer Antigen Business (2015-2020) 9.9.5 Xiamen Baysen Medica Tech Recent Development 10 Analyst's Viewpoints/Conclusions 11 Appendix 11.1 Research Methodology 11.1.1 Methodology/Research Approach 11.1.2 Data Source 11.2 Disclaimer 11.3 Author Details

List of Tables Table 1. Cancer Antigen Key Market Segments Table 2. Key Players Covered: Ranking by Cancer Antigen Revenue Table 3. Ranking of Global Top Cancer Antigen Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Cancer Antigen Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Cancer Antigen 125 Table 6. Key Players of Cancer Antigen 15-3 Table 7. Key Players of Cancer Antigen 27-29 Table 8. Key Players of Cancer Antigen 19-9 Table 9. Key Players of Others Table 10. COVID-19 Impact Global Market: (Four Cancer Antigen Market Size Forecast Scenarios) Table 11. Opportunities and Trends for Cancer Antigen Players in the COVID-19 Landscape Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 13. Key Regions/Countries Measures against Covid-19 Impact Table 14. Proposal for Cancer Antigen Players to Combat Covid-19 Impact Table 15. Global Cancer Antigen Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 16. Global Cancer Antigen Market Size by Regions (US$ Million): 2020 VS 2026 Table 17. Global Cancer Antigen Market Size by Regions (2015-2020) (US$ Million) Table 18. Global Cancer Antigen Market Share by Regions (2015-2020) Table 19. Global Cancer Antigen Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 20. Global Cancer Antigen Market Share by Regions (2021-2026) Table 21. Market Top Trends Table 22. Key Drivers: Impact Analysis Table 23. Key Challenges Table 24. Cancer Antigen Market Growth Strategy Table 25. Main Points Interviewed from Key Cancer Antigen Players Table 26. Global Cancer Antigen Revenue by Players (2015-2020) (Million US$) Table 27. Global Cancer Antigen Market Share by Players (2015-2020) Table 28. Global Top Cancer Antigen Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Antigen as of 2019) Table 29. Global Cancer Antigen by Players Market Concentration Ratio (CR5 and HHI) Table 30. Key Players Headquarters and Area Served Table 31. Key Players Cancer Antigen Product Solution and Service Table 32. Date of Enter into Cancer Antigen Market Table 33. Mergers & Acquisitions, Expansion Plans Table 34. Global Cancer Antigen Market Size by Type (2015-2020) (Million US$) Table 35. Global Cancer Antigen Market Size Share by Type (2015-2020) Table 36. Global Cancer Antigen Revenue Market Share by Type (2021-2026) Table 37. Global Cancer Antigen Market Size Share by Application (2015-2020) Table 38. Global Cancer Antigen Market Size by Application (2015-2020) (Million US$) Table 39. Global Cancer Antigen Market Size Share by Application (2021-2026) Table 40. North America Key Players Cancer Antigen Revenue (2019-2020) (Million US$) Table 41. North America Key Players Cancer Antigen Market Share (2019-2020) Table 42. North America Cancer Antigen Market Size by Type (2015-2020) (Million US$) Table 43. North America Cancer Antigen Market Share by Type (2015-2020) Table 44. North America Cancer Antigen Market Size by Application (2015-2020) (Million US$) Table 45. North America Cancer Antigen Market Share by Application (2015-2020) Table 46. Europe Key Players Cancer Antigen Revenue (2019-2020) (Million US$) Table 47. Europe Key Players Cancer Antigen Market Share (2019-2020) Table 48. Europe Cancer Antigen Market Size by Type (2015-2020) (Million US$) Table 49. Europe Cancer Antigen Market Share by Type (2015-2020) Table 50. Europe Cancer Antigen Market Size by Application (2015-2020) (Million US$) Table 51. Europe Cancer Antigen Market Share by Application (2015-2020) Table 52. Asia-Pacific Key Players Cancer Antigen Revenue (2019-2020) (Million US$) Table 53. Asia-Pacific Key Players Cancer Antigen Market Share (2019-2020) Table 54. Asia-Pacific Cancer Antigen Market Size by Type (2015-2020) (Million US$) Table 55. Asia-Pacific Cancer Antigen Market Share by Type (2015-2020) Table 56. Asia-Pacific Cancer Antigen Market Size by Application (2015-2020) (Million US$) Table 57. Asia-Pacific Cancer Antigen Market Share by Application (2015-2020) Table 58. Thermo Fisher Scientific Company Details Table 59. Thermo Fisher Scientific Business Overview Table 60. Thermo Fisher Scientific Product Table 61. Thermo Fisher Scientific Revenue in Cancer Antigen Business (2015-2020) (Million US$) Table 62. Thermo Fisher Scientific Recent Development Table 63. Roche Company Details Table 64. Roche Business Overview Table 65. Roche Product Table 66. Roche Revenue in Cancer Antigen Business (2015-2020) (Million US$) Table 67. Roche Recent Development Table 68. Tellgen Company Details Table 69. Tellgen Business Overview Table 70. Tellgen Product Table 71. Tellgen Revenue in Cancer Antigen Business (2015-2020) (Million US$) Table 72. Tellgen Recent Development Table 73. Labor Diagnostika Nord Company Details Table 74. Labor Diagnostika Nord Business Overview Table 75. Labor Diagnostika Nord Product Table 76. Labor Diagnostika Nord Revenue in Cancer Antigen Business (2015-2020) (Million US$) Table 77. Labor Diagnostika Nord Recent Development Table 78. Henso Medical (Hangzhou) Company Details Table 79. Henso Medical (Hangzhou) Business Overview Table 80. Henso Medical (Hangzhou) Product Table 81. Henso Medical (Hangzhou) Revenue in Cancer Antigen Business (2015-2020) (Million US$) Table 82. Henso Medical (Hangzhou) Recent Development Table 83. Multisciences (Lianke) Biotech Company Details Table 84. Multisciences (Lianke) Biotech Business Overview Table 85. Multisciences (Lianke) Biotech Product Table 86. Multisciences (Lianke) Biotech Revenue in Cancer Antigen Business (2015-2020) (Million US$) Table 87. Multisciences (Lianke) Biotech Recent Development Table 88. Hangzhou AllTest Biotech Company Details Table 89. Hangzhou AllTest Biotech Business Overview Table 90. Hangzhou AllTest Biotech Product Table 91. Hangzhou AllTest Biotech Revenue in Cancer Antigen Business (2015-2020) (Million US$) Table 92. Hangzhou AllTest Biotech Recent Development Table 93. SHINJIN Medics Business Overview Table 94. SHINJIN Medics Product Table 95. SHINJIN Medics Company Details Table 96. SHINJIN Medics Revenue in Cancer Antigen Business (2015-2020) (Million US$) Table 97. SHINJIN Medics Recent Development Table 98. Xiamen Baysen Medica Tech Company Details Table 99. Xiamen Baysen Medica Tech Business Overview Table 100. Xiamen Baysen Medica Tech Product Table 101. Xiamen Baysen Medica Tech Revenue in Cancer Antigen Business (2015-2020) (Million US$) Table 102. Xiamen Baysen Medica Tech Recent Development Table 103. Research Programs/Design for This Report Table 104. Key Data Information from Secondary Sources Table 105. Key Data Information from Primary Sources List of Figures Figure 1. Global Cancer Antigen Market Share by Type: 2020 VS 2026 Figure 2. Cancer Antigen 125 Features Figure 3. Cancer Antigen 15-3 Features Figure 4. Cancer Antigen 27-29 Features Figure 5. Cancer Antigen 19-9 Features Figure 6. Others Features Figure 7. Global Cancer Antigen Market Share by Application: 2020 VS 2026 Figure 8. Hospitals Case Studies Figure 9. Diagnostic Centres Case Studies Figure 10. Ambulatory Surgical Centres Case Studies Figure 11. Others Case Studies Figure 12. Cancer Antigen Report Years Considered Figure 13. Global Cancer Antigen Market Size YoY Growth 2015-2026 (US$ Million) Figure 14. Global Cancer Antigen Market Share by Regions: 2020 VS 2026 Figure 15. Global Cancer Antigen Market Share by Regions (2021-2026) Figure 16. Porter's Five Forces Analysis Figure 17. Global Cancer Antigen Market Share by Players in 2019 Figure 18. Global Top Cancer Antigen Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Antigen as of 2019 Figure 19. The Top 10 and 5 Players Market Share by Cancer Antigen Revenue in 2019 Figure 20. North America Cancer Antigen Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Europe Cancer Antigen Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Asia-Pacific Cancer Antigen Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Thermo Fisher Scientific Revenue Growth Rate in Cancer Antigen Business (2015-2020) Figure 25. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Roche Revenue Growth Rate in Cancer Antigen Business (2015-2020) Figure 27. Tellgen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Tellgen Revenue Growth Rate in Cancer Antigen Business (2015-2020) Figure 29. Labor Diagnostika Nord Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Labor Diagnostika Nord Revenue Growth Rate in Cancer Antigen Business (2015-2020) Figure 31. Henso Medical (Hangzhou) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Henso Medical (Hangzhou) Revenue Growth Rate in Cancer Antigen Business (2015-2020) Figure 33. Multisciences (Lianke) Biotech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Multisciences (Lianke) Biotech Revenue Growth Rate in Cancer Antigen Business (2015-2020) Figure 35. Hangzhou AllTest Biotech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Hangzhou AllTest Biotech Revenue Growth Rate in Cancer Antigen Business (2015-2020) Figure 37. SHINJIN Medics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. SHINJIN Medics Revenue Growth Rate in Cancer Antigen Business (2015-2020) Figure 39. Xiamen Baysen Medica Tech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Xiamen Baysen Medica Tech Revenue Growth Rate in Cancer Antigen Business (2015-2020) Figure 41. Bottom-up and Top-down Approaches for This Report Figure 42. Data Triangulation Figure 43. Key Executives Interviewed

Thermo Fisher Scientific Roche Tellgen Labor Diagnostika Nord Henso Medical (Hangzhou) Multisciences (Lianke) Biotech Hangzhou AllTest Biotech SHINJIN Medics Xiamen Baysen Medica Tech